The prevalence of iron deficiency anemia (IDA) has dropped significantly in the United States during the past 3 decades (1, 2). The third National Health and Nutrition Examination Survey (NHANES III, 1988 -1994 showed that for both sexes combined (n = 1339) the prevalence of IDA was ≤ 3% for children aged 1-2 y and < 1% for children aged 3-5 y. This decline was found among middle-and low-income children, although there was significant variability among minority groups, particularly among children < 2 y of age (3) (4) (5) . Prevalence rates for some low-income children in some states, however, are still much higher than those for the whole country (6) . For example, in Solano and Alameda counties in northern California, ≥ 30% of children tested were determined to be anemic (P Scariati, unpublished observations, 1996). Because the anemia rates for these and other California counties were high, researchers from the Centers for Disease Control and Prevention recently evaluated the validity of the anemia data obtained in Alameda, Sacramento, and Fresno counties. There was evidence of measurement error within some of the clinics in these 3 counties, but anemia rates still appeared to be higher than the national average. In the United States, iron deficiency is the primary determinant of anemia.
Thus, if early anemia is a cause of mild or moderate mental retardation, then the problem of IDA still demands consistent public health attention as suggested by Hurtado et al (7) in this issue of the Journal. The epidemiologic evidence presented by Hurtado et al is compelling and agrees with 2 sets of findings published previously. IDA during the first 2 y of life was associated with poor performance on tests of intelligence or specific cognitive processes at or near school age in Israel, Costa Rica, and Chile (8) . Also, with one exception (9), delays in mental development observed in infants and toddlers with IDA were not fully reversed after the children were treated with iron (10).
Dallman et al (11) showed that in rats given an iron-deficient diet from 10 to 28 or 48 d of age a deficiency of nonheme iron in the brain was not corrected after nutritional rehabilitation. Also, iron-deficient diets given to adolescent rats during gestation and lactation lowered the concentration of brain iron in pups at 3 mo of age (12) . It is thus plausible that the associations between IDA and long-term intellectual deficits are mediated by either anatomic or neurochemical changes. More specifically, existing data point to changes in the dopaminergic system and hypomyelination (13, 14) .
The information above strongly justifies the inclusion of IDA as a risk factor for determining eligibility for the Special Supplemental Program for Women, Infants, and Children (WIC) (15) . However, the public health and scientific conclusions that should be drawn from Hurtado et al's (7) data are not equivalent. Definitive conclusions from all information currently available regarding the long-term functional consequences of IDA or the irreversibility of the early functional alterations it produces are scientifically unwarranted. The study reported by Hurtado et al (7), based on a large data set (n = 5411) that linked records from the WIC program with records from public schools in Dade County, FL, is illustrative. For each decrement in hemoglobin concentration (g/L), the risk of mild or moderate retardation increased (1.28) after several potential confounders were controlled for. Birth weight, maternal education, sex, and age of the mother also predicted anemia but the odds ratio in each of these cases was > 1.28.
The "early trauma later deficit" hypothesis has a long-standing history in developmental psychobiology, although most researchers fully recognize that caution must be exercised before drawing definitive conclusions because of the inherent problems of controlling for confounders. Controlled experimental trials that follow children with IDA from infancy to the school period are unethical and, therefore, unavailable. Based on their work, Lozoff et al (16) carefully pointed at the limitations of quasiexperimental longitudinal research regarding the long-term developmental consequences of early IDA. The authors noted the possibility that social environmental factors that remained untapped accounted for the cognitive differences observed at 5 y of age between children who did and did not have IDA in early life. IDA in the United States and elsewhere is more likely to occur among poor, minority children (6) . Data generated by NHANES III show that lower-income, minority status and lower parental education are independently associated with lower scores on cognitive outcomes (17) .
In the study in Dade County, FL (7), the problem of confounders is also tied to the outcomes. Mildly to moderately retarded children do not constitute a homogeneous group, etiologically or functionally. Besides genetic factors (eg, chromosomal and metabolic), multiple prenatal (eg, alcohol exposure and intrauterine growth retardation) and postnatal (eg, anoxia and homelessness) biological and socioeconomic factors cause learning disabilities and retardation (18) . Learning disabilities and Early iron deficiency anemia and later mental retardation 1, 2 Ernesto Pollitt mental retardation represent either a general developmental lag or include several specific cognitive dysfunctions that, when combined, interfere with school progress and performance in most or all areas of learning. No existing data suggest that IDA interferes with several cognitive functions; in fact, the particular functions at highest risk remain unknown. Iron is not equally distributed in all regions of the brain and it is unlikely that IDA will equally affect all of the neural substrates of cognitive function (19, 20) .
In light of the small effect estimated in Dade County, the issue of confounding, and the heterogeneity of the target population, the findings (7) should be interpreted cautiously. This study does, however, add useful information to the substantive body of data building on the role of IDA as a developmental risk factor.
